Offer - Urjas Oil for just ₹ 1 X
Cefoprox CV 100 Mg Dry Syrup is a prescription drug, available for use as Syrup. The alternative uses of Cefoprox CV 100 Mg Dry Syrup have also been explained below.
The optimal dosage of Cefoprox CV 100 Mg Dry Syrup is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Some other side effects of Cefoprox CV 100 Mg Dry Syrup have been listed ahead. Usually, these side effects of Cefoprox CV 100 Mg Dry Syrup go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Cefoprox CV 100 Mg Dry Syrup's effect during pregnancy is Mild and Moderate while nursing. Warnings related to Cefoprox CV 100 Mg Dry Syrup's effects on the liver, heart and kidney, if any, have been listed below.
Cefoprox CV 100 Mg Dry Syrup is contraindicated in people with pre-existing medical conditions like Jaundice as it can result in adverse effects. Other conditions have been mentioned below in the Cefoprox CV 100 Mg Dry Syrup contraindications section.
Besides this, Cefoprox CV 100 Mg Dry Syrup may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Cefoprox CV 100 Mg Dry Syrup is considered safe while driving, and is addictive.
Cefoprox CV 100 Mg Dry Syrup is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
2 - 12 years (Child) |
|
Is the use of Cefoprox CV 100 Mg Dry Syrup safe for pregnant women?
Cefoprox CV has little to no side effects in pregnant women.
Is the use of Cefoprox CV 100 Mg Dry Syrup safe during breastfeeding?
Cefoprox CV can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Cefoprox CV 100 Mg Dry Syrup on the Kidneys?
There can be some harmful effects on your kidneys after taking Cefoprox CV. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Cefoprox CV 100 Mg Dry Syrup on the Liver?
The liver can be affected by Cefoprox CV. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Cefoprox CV only after medical advice.
What is the effect of Cefoprox CV 100 Mg Dry Syrup on the Heart?
Very few cases of side effects of Cefoprox CV on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Cefoprox CV 100 Mg Dry Syrup unless your doctor advises you to do so -
Is this Cefoprox CV 100 Mg Dry Syrup habit forming or addictive?
Forming a habit of Cefoprox CV 100 Mg Dry Syrup has not been reported.
Interaction between Food and Cefoprox CV 100 Mg Dry Syrup
Taking Cefoprox CV 100 Mg Dry Syrup with food does not cause any problems.
Interaction between Alcohol and Cefoprox CV 100 Mg Dry Syrup
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Cefoprox CV 100 Mg Dry Syrup.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311